Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Helix BioPharma Corp (TO: HBP)

 
HBP Technical Analysis
5
As on 9th Jun 2023 HBP STOCK Price closed @ 0.20 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.25 & Strong Sell for SHORT-TERM with Stoploss of 0.34 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

HBPSTOCK Price

Open 0.20 Change Price %
High 0.20 1 Day -0.01 -4.76
Low 0.20 1 Week -0.01 -4.76
Close 0.20 1 Month -0.02 -9.09
Volume 2000 1 Year -0.29 -59.18
52 Week High 0.54 | 52 Week Low 0.17
 
TO Canada Most Active Stocks
YRI 7.89 0.13%
CNQ 75.27 0.40%
UEX 0.50 16.28%
SU 40.43 0.02%
SJR-B 40.48 0.02%
OREA 0.02 -77.78%
VFF 8.12 0.87%
ENB 50.62 -0.80%
TD 79.12 0.16%
AC 22.37 0.22%
 
TO Canada Top Gainers Stocks
AAB 0.05 25.00%
AAB 0.05 25.00%
HLS 5.88 24.31%
HLS 5.88 24.31%
HLS 5.88 24.31%
HLS 5.88 24.31%
HLS 5.88 24.31%
HLS 5.88 24.31%
UEX 0.50 16.28%
WM 0.16 14.29%
 
TO Canada Top Losers Stocks
OREA 0.02 -77.78%
OREA 0.02 -77.78%
NCF 0.02 -33.33%
GLG 0.05 -16.67%
GLG 0.05 -16.67%
CWEB-WR 0.10 -16.67%
GTMS 0.97 -15.65%
TMD 0.18 -14.29%
TMD 0.18 -14.29%
TMD 0.18 -14.29%
 
 
HBP
Daily Charts		 HBP
Intraday Charts		 Whats New @
Bazaartrend		 HBP
Free Analysis
 
HBP Important Levels Intraday
RESISTANCE0.20
RESISTANCE0.20
RESISTANCE0.20
RESISTANCE0.20
RESISTANCE0.20
RESISTANCE0.20
RESISTANCE0.20
RESISTANCE0.20
 
HBP Forecast May 2024
Share
4th UP Forecast0.62
3rd UP Forecast0.49
2nd UP Forecast0.4
1st UP Forecast0.32
1st DOWN Forecast0.08
2nd DOWN Forecast0
3rd DOWN Forecast-0.09
4th DOWN Forecast-0.22
 
HBP Weekly Forecast
4th UP Forecast0.32
3rd UP Forecast0.28
2nd UP Forecast0.26
1st UP Forecast0.23
1st DOWN Forecast0.17
2nd DOWN Forecast0.14
3rd DOWN Forecast0.12
4th DOWN Forecast0.08
 
HBP Forecast2024
4th UP Forecast0.93
3rd UP Forecast0.7
2nd UP Forecast0.55
1st UP Forecast0.41
1st DOWN Forecast-0.01
2nd DOWN Forecast-0.15
3rd DOWN Forecast-0.3
4th DOWN Forecast-0.53
 
 
HBP Other Details
Segment EQ
Market Capital 74800480.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
HBP Address
HBP
 
HBP Latest News
 
Your Comments and Response on Helix BioPharma Corp
 
HBP Business Profile
Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with ProMab Biotechnologies, Inc. to develop novel antibody and chimeric antigen receptor T-cell therapy to treat multiple myeloma, as well as a license agreements with Xisle Pharma Ventures Trust and National Research of Council Canada. The company is headquartered in Richmond Hill, Canada. Address: 9120 Leslie Street, Richmond Hill, ON, Canada, L4B 3J9
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service